BSE Live
Sep 08, 16:01Prev. Close
3579.95
Open Price
3558.15
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Sep 08, 15:47Prev. Close
3579.10
Open Price
3581.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
3612.90 (88)
Profit & Loss account of Torrent Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
INCOME | ||||||
Revenue From Operations [Gross] | 9,485.06 | 8,369.59 | 7,546.76 | 6,665.96 | 6,333.04 | |
Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Revenue From Operations [Net] | 9,485.06 | 8,369.59 | 7,546.76 | 6,665.96 | 6,333.04 | |
Total Operating Revenues | 9,682.44 | 8,532.90 | 7,695.20 | 6,742.32 | 6,450.57 | |
Other Income | 31.50 | 91.36 | 81.88 | 204.17 | 118.34 | |
Total Revenue | 9,713.94 | 8,624.26 | 7,777.08 | 6,946.49 | 6,568.91 | |
EXPENSES | ||||||
Cost Of Materials Consumed | 1,517.51 | 1,651.91 | 1,477.42 | 1,528.60 | 1,420.82 | |
Purchase Of Stock-In Trade | 732.33 | 548.48 | 533.56 | 397.24 | 398.99 | |
Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Changes In Inventories Of FG,WIP And Stock-In Trade | -9.04 | -68.61 | 128.44 | -18.34 | -150.14 | |
Employee Benefit Expenses | 1,636.45 | 1,450.67 | 1,251.22 | 1,097.93 | 1,097.12 | |
Finance Costs | 213.40 | 303.04 | 297.68 | 236.29 | 334.12 | |
Depreciation And Amortisation Expenses | 759.48 | 761.05 | 672.34 | 602.43 | 609.84 | |
Other Expenses | 2,229.42 | 2,061.15 | 1,839.40 | 1,636.13 | 1,492.05 | |
Total Expenses | 7,079.55 | 6,707.69 | 6,200.06 | 5,480.28 | 5,202.80 | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 2,634.39 | 1,916.57 | 1,577.02 | 1,466.21 | 1,366.11 | |
Exceptional Items | -24.21 | 0.00 | 0.00 | 0.00 | 0.00 | |
Profit/Loss Before Tax | 2,610.18 | 1,916.57 | 1,577.02 | 1,466.21 | 1,366.11 | |
Tax Expenses-Continued Operations | ||||||
Current Tax | 540.56 | 321.67 | 274.20 | 253.27 | 247.77 | |
Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax | 181.56 | 237.82 | 251.43 | 221.49 | -19.51 | |
Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Tax Expenses | 722.12 | 559.49 | 525.63 | 474.76 | 228.26 | |
Profit/Loss After Tax And Before ExtraOrdinary Items | 1,888.06 | 1,357.08 | 1,051.39 | 991.45 | 1,137.85 | |
Profit/Loss From Continuing Operations | 1,888.06 | 1,357.08 | 1,051.39 | 991.45 | 1,137.85 | |
Profit/Loss For The Period | 1,888.06 | 1,357.08 | 1,051.39 | 991.45 | 1,137.85 | |
OTHER ADDITIONAL INFORMATION | ||||||
EARNINGS PER SHARE | ||||||
Basic EPS (Rs.) | 55.79 | 40.10 | 31.07 | 58.59 | 67.24 | |
Diluted EPS (Rs.) | 55.79 | 40.10 | 31.07 | 58.59 | 67.24 | |
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
Equity Share Dividend | 1,083.03 | 1,015.34 | 863.03 | 676.89 | 338.45 | |
Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Equity Dividend Rate (%) | 640.00 | 560.00 | 440.00 | 960.00 | 700.00 |
01.09.2025
03.08.2025
Chartist Talk: Rahul Ghose sees choppy August for Nifty, expects continued Bank Nifty outperformance
29.07.2025
Accumulate Torrent Pharmaceuticals; target of Rs 4000: Prabhudas Lilladher
29.07.2025
Torrent Pharma Consolidated June 2025 Net Sales at Rs 3,178.00 crore, up 11.16% Y-o-Y
29.07.2025
Torrent Pharma Consolidated June 2025 Net Sales at Rs 3,178.00 crore, up 11.16% Y-o-Y
29.07.2025
Torrent Pharma Standalone June 2025 Net Sales at Rs 2,616.00 crore, up 7.3% Y-o-Y
21.05.2025
Torrent Pharma Standalone March 2025 Net Sales at Rs 2,433.00 crore, up 13.53% Y-o-Y
28.01.2025
Torrent Pharma Consolidated December 2024 Net Sales at Rs 2,809.00 crore, up 2.82% Y-o-Y
12.07.2023
Torrent Pharma Q1 PAT may dip 9.7% YoY to Rs 319.7 cr: Nirmal Bang
17.01.2023
Torrent Pharma Q3 PAT seen up 28.9% YoY to Rs 3,211 cr: Nirmal Bang
13.07.2022
Torrent Pharma Q1 PAT seen up 2.8% YoY to Rs 339.1 cr: ICICI Direct
08.07.2022
Torrent Pharmaceuticals Q1 PAT seen up 1.4% YoY to Rs 334.5 cr: Prabhudas Lilladher
24.07.2019
Torrent Pharma shares jump 6% as brokerages remain bullish after Q1 show
25.08.2018
Pharma Q1 review: Brokerages say performance a mixed bag, but are upbeat on domestic biz
22.01.2014
14.01.2012